Contrary to previous studies describing reduced antioxidant capacity in FA [7,33,34], our findings showed no significant differences in RBCs basal GSH levels and in the activities of total SOD, MnSOD, and CuZnSOD between FA patients, FA carriers, and controls. The gene discussed is SOD1; the disease is Friedreich ataxia.